JP2021525225A5 - - Google Patents
Info
- Publication number
- JP2021525225A5 JP2021525225A5 JP2020551516A JP2020551516A JP2021525225A5 JP 2021525225 A5 JP2021525225 A5 JP 2021525225A5 JP 2020551516 A JP2020551516 A JP 2020551516A JP 2020551516 A JP2020551516 A JP 2020551516A JP 2021525225 A5 JP2021525225 A5 JP 2021525225A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- sde
- diisopropyl adipate
- caprylic
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650108P | 2018-03-29 | 2018-03-29 | |
| US62/650,108 | 2018-03-29 | ||
| PCT/US2019/024706 WO2019191511A1 (en) | 2018-03-29 | 2019-03-28 | Compositions and methods for treating pruritus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525225A JP2021525225A (ja) | 2021-09-24 |
| JP2021525225A5 true JP2021525225A5 (https=) | 2022-04-11 |
| JPWO2019191511A5 JPWO2019191511A5 (https=) | 2022-04-11 |
Family
ID=68054657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551516A Pending JP2021525225A (ja) | 2018-03-29 | 2019-03-28 | 掻痒症を治療するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20190298702A1 (https=) |
| EP (1) | EP3755328A4 (https=) |
| JP (1) | JP2021525225A (https=) |
| KR (1) | KR20200138730A (https=) |
| CN (1) | CN112040948A (https=) |
| AU (1) | AU2019243571A1 (https=) |
| BR (1) | BR112020019094A2 (https=) |
| CA (1) | CA3094710A1 (https=) |
| IL (1) | IL277463A (https=) |
| MX (1) | MX2020009813A (https=) |
| RU (1) | RU2020130919A (https=) |
| TW (1) | TWI729371B (https=) |
| WO (1) | WO2019191511A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113797167B (zh) * | 2020-06-16 | 2024-05-10 | 苏州恩华生物医药科技有限公司 | 一种塞纳布啡的储库制剂 |
| CA3186630A1 (en) * | 2020-06-30 | 2022-01-06 | Dermira, Inc. | Irak4 inhibitors and topical uses thereof |
| WO2022175973A1 (en) * | 2021-02-18 | 2022-08-25 | Navin Saxena Research And Technology Private Limited | An injectable composition for long term delivery of nalbuphine or nalbuphine ester prodrug or its salts and use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130759C (https=) * | 1965-10-07 | |||
| US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
| US6225321B1 (en) * | 1997-06-05 | 2001-05-01 | Oliver Yoa-Pu Hu | Long analgesic acting nalbuphine polyester derivative and method of use |
| US6503944B1 (en) * | 1999-05-26 | 2003-01-07 | The Andrew Jergens Company | Anhydrous skin care composition |
| US6967023B1 (en) * | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| ES2188481T3 (es) * | 2000-04-27 | 2003-07-01 | Oliver Yoa-Pu Hu | Derivados de polinalbufina. |
| US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| US20070093517A1 (en) * | 2005-10-24 | 2007-04-26 | Gary Newton | Local anesthetic compositions |
| CA2788440A1 (en) * | 2010-02-26 | 2011-09-01 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| EP2788028B1 (en) * | 2011-12-08 | 2019-03-27 | Rigel Pharmaceuticals, Inc. | Topical formulation for administering a compound |
| US20140112957A1 (en) * | 2012-10-19 | 2014-04-24 | Oliver Yao-Pu Hu | Analegisic (Sebacoyl dinalbuphine ester) PLGA controlled release formulation form |
| MX2016016404A (es) * | 2014-06-13 | 2017-11-30 | Trevi Therapeutics Inc | Metodos para el tratamiento del prurito. |
| EP3302477B1 (en) * | 2015-05-28 | 2024-02-07 | Lumosa Therapeutics Co., Ltd. | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester |
-
2019
- 2019-03-28 RU RU2020130919A patent/RU2020130919A/ru unknown
- 2019-03-28 JP JP2020551516A patent/JP2021525225A/ja active Pending
- 2019-03-28 US US16/368,609 patent/US20190298702A1/en not_active Abandoned
- 2019-03-28 CA CA3094710A patent/CA3094710A1/en not_active Abandoned
- 2019-03-28 TW TW108111046A patent/TWI729371B/zh not_active IP Right Cessation
- 2019-03-28 CN CN201980023503.1A patent/CN112040948A/zh active Pending
- 2019-03-28 MX MX2020009813A patent/MX2020009813A/es unknown
- 2019-03-28 BR BR112020019094-2A patent/BR112020019094A2/pt not_active Application Discontinuation
- 2019-03-28 KR KR1020207027179A patent/KR20200138730A/ko not_active Ceased
- 2019-03-28 EP EP19776964.9A patent/EP3755328A4/en not_active Withdrawn
- 2019-03-28 WO PCT/US2019/024706 patent/WO2019191511A1/en not_active Ceased
- 2019-03-28 AU AU2019243571A patent/AU2019243571A1/en not_active Abandoned
-
2020
- 2020-09-21 IL IL277463A patent/IL277463A/en unknown
-
2022
- 2022-04-29 US US17/661,444 patent/US20220362226A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7324210B2 (ja) | トファシチニブを含む局所製剤 | |
| US8293790B2 (en) | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof | |
| KR100619228B1 (ko) | 국소피부전달 무수조성물 및 상기 조성물을 약제로 포함하는 국소 피부 치료용 조성물 | |
| EP2450035B1 (en) | Combination of adapalene and benzoyl peroxide for treating acne lesions | |
| AU2019200064A1 (en) | Topical compositions of flunisolide and methods of treatment | |
| JP7578651B2 (ja) | ジアセレインまたはレインの局所製剤およびその使用 | |
| US20160287614A1 (en) | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic | |
| US20200345671A1 (en) | Topical pharmaceutical composition of adapalene and minocycline | |
| CN101972225A (zh) | 一种含吡非尼酮的凝胶组合物 | |
| JP2021525225A5 (https=) | ||
| RU2020130919A (ru) | Композиции и способы для лечения зуда | |
| US10123970B2 (en) | Topical retinoid solutions | |
| US8524774B1 (en) | Topical two step polytherapy for treatment of psoriasis and other skin disorders | |
| US12491192B2 (en) | Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response | |
| JPWO2019191511A5 (https=) | ||
| EP2505195B1 (en) | Topical pharmaceutical compositions of ketoprofen and methylsulfonylmethane | |
| US20130197089A1 (en) | Compositions for the treatment of actinic keratosis | |
| US10022348B2 (en) | Topical solution of isotretinoin | |
| US20200230082A1 (en) | Topical acetaminophen formulations for itch relief | |
| CA3118698A1 (en) | Teriflunomide topical pharmaceutical compositions | |
| JP7514598B2 (ja) | 皮膚外用組成物 | |
| CN118662507A (zh) | 一种改善黄褐斑的外用组合物 | |
| BG65352B1 (bg) | Средство за лечение на псориазис | |
| CA3174475A1 (en) | Topical pharmaceutical formulations of a cyclic depsipeptide | |
| KR20150128952A (ko) | 플루니솔리드의 국소 조성물 및 치료 방법 |